Award
National Institute of Allergy and Infectious Diseases 5R01AI172541-04
Sustained Release of Potent Antiviral Prodrugs for HIV Prevention
Recipient
National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH
Award Amount
$808,442.00
Ceiling
$808,442.00
Awarded
June 25, 2026
Identifier
5R01AI172541-04
NIH/NIAID awarded a research project to develop long-acting implant systems for HIV prevention through sustained drug delivery.
Description
This is a research project funded by NIH/NIAID focusing on developing long-acting implant systems for HIV prophylaxis, involving chemical synthesis, drug screening, biomedical device engineering, and pharmacology research. The project aims to improve HIV prevention strategies through sustained drug delivery systems.